All Stories

  1. An Expedition on Synthetic Methodology of FDA-approved Anticancer Drugs (2018-2021)
  2. Current Trends in the Development of EGFR Inhibitors as Promising Anticancer Agents: Sar and Synthetic Studies from (2010-2020)